Login / Signup

Assessment of Novel Therapeutics to Improve Access to Transplantation for Highly Sensitized Patients in a Shifting Clinical Landscape.

James H Lan
Published in: Journal of the American Society of Nephrology : JASN (2024)
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • prognostic factors
  • cell therapy
  • mesenchymal stem cells